20 LATEST RESOURCES (159 INDEXED)
A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 2: Negative Symptoms in Schizophrenia · June 2023
Multimedia (Interviews-Authors)
Neuropsychiatric Disease and Treatment
A Patient-Clinician Discussion of Current Challenges in Schizophrenia Part 1: Addressing Daily Functioning and Cognitive Impairments Associated with Schizophrenia · June 2023
Multimedia (Interviews-Authors)
Neuropsychiatric Disease and Treatment
Assessment of Neuroanatomical Endophenotypes of Autism Spectrum Disorder and Association with Characteristics of Individuals with Schizophrenia and the General Population · April 2023
Multimedia (Interviews-Authors)
JAMA Psychiatry
Clinical Recovery and Long-Term Association of Specialized Early Intervention Services vs Treatment as Usual among Individuals with First-Episode Schizophrenia Spectrum Disorder: 20-Year Follow-Up of the OPUS Trial · February 2023
Multimedia (Interviews-Authors)
JAMA Psychiatry
Postpartum Psychosis or Something Else? · January 2023
Multimedia (Interviews-Authors)
Primary Care Companion for CNS Disorders
Effect of Technology-Enhanced Screening in Addition to Standard Targeted Clinician Education on the Duration of Untreated Psychosis: A Cluster Randomized Clinical Trial · January 2023
Multimedia (Interviews-Authors)
JAMA Psychiatry
Heritability of Psychotic Experiences in Adolescents and Interaction with Environmental Risk · August 2022
Multimedia (Interviews-Authors)
JAMA Psychiatry
Assessment of Noninvasive Brain Stimulation Interventions for Negative Symptoms of Schizophrenia: A Systematic Review and Network Meta-Analysis · June 2022
Multimedia (Interviews-Authors)
JAMA Psychiatry
Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age · August 2021
Multimedia (Interviews-Authors)
JAMA Internal Medicine
Association Between Cardiovascular Risk Factors and Cognitive Impairment in People with Schizophrenia: A Systematic Review and Meta-Analysis · March 2021
Multimedia (Interviews-Authors)
JAMA Psychiatry
Longitudinal Evaluation of Functional and Clinical Outcomes in Clinical High-Risk for Psychosis with and without a History of ADHD and Stimulant Exposure · April 2019
Multimedia (Lectures-Conferences)
University of Arizona
Pharmacology of Early Psychosis · March 2019
Multimedia (Lectures-Conferences)
University of Connecticut
Early Detection and Prevention of Psychotic Disorders: Ready for “Prime Time”? · February 2019
Multimedia (Lectures-Conferences)
Brain and Behavior Research Foundation
Treatment Resistant Schizophrenia and ECT · January 2019
Multimedia (Lectures-Conferences)
University of Arizona
Age-Associated Deviations of Amygdala Functional Connectivity in Youths with Psychosis Spectrum Disorders: Relevance to Psychotic Symptoms · January 2019
Multimedia (Interviews-Research)
American Journal of Psychiatry
Antipsychotics and the Metabolic Syndrome · January 2019
Multimedia (Lectures-Conferences)
University of Connecticut
Aging with Schizophrenia: Bad News and Good News · November 2018
Multimedia (Lectures-Conferences)
YouTube>University of Washington
Schizophrenia Polygenic Risk Score as a Predictor of Antipsychotic Efficacy in First-Episode Psychosis · November 2018
Multimedia (Interviews-Research)
American Journal of Psychiatry
The Benefit of Minocycline on Negative Symptoms of Schizophrenia in Patients with Recent-Onset Psychosis (BeneMin): A Randomised, Double-Blind, Placebo-Controlled Trial · October 2018
Multimedia (Interviews-Research)
Lancet Psychiatry
Predicting Psychosis in Patients with Prodromal Symptoms: The NAPLS Study (Meetings-Events) · October 2018
Multimedia (Lectures-Conferences)
European College of Neuropsychopharmacology